A D S Diagnostic Ltd vs Divi's Laboratories Limited

A side-by-side comparison of A D S Diagnostic Ltd (523031) and Divi's Laboratories Limited (DIVISLAB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Divi's Laboratories Limited leads 523031 vs DIVISLAB on 8 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability13
  • Growth20
  • Size & financial health03
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
94.52
0.00
P/B ratio
14.90
0.00%
Dividend yield
0.32%
₹4.88
EPS
₹96.75

Profitability

DIVISLAB takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

15.20%
Return on equity
15.32%
21.09%
Return on capital
20.35%
7.41%
EBITDA margin
32.59%
3.76%
Net margin
24.32%

Growth

523031 takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

28.94%
Revenue CAGR (3Y)
10.78%
37.68%
Profit CAGR (3Y)
12.09%

Size & financial health

DIVISLAB takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹0 Cr
Market cap
₹2.45L Cr
₹28 Cr
Revenue
₹10,560 Cr
₹1 Cr
Net profit
₹2,568 Cr
0.00
Debt / equity even
0.00
A D S Diagnostic Ltd
  • + ["Stock is trading at 0.33 times its book value", "Stock is providing a good dividend yield of 8.82%.", "Company has been maintaining a healthy dividend payout of 17.4%", "Debtor days have improved from 80.2 to 63.7 days.", "Company's working capital requirements have reduced from 76.9 days to 61.1 days"]
  • − ["Company's cost of borrowing seems high"]
Divi's Laboratories Limited
  • + ["Company has been maintaining a healthy dividend payout of 31.0%", "Company is almost debt free."]
  • − ["Stock is trading at 14.60 times its book value", "The company has delivered a poor sales growth of 8.7% over past five years."]
A D S Diagnostic Ltd full analysis Divi's Laboratories Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

523031 vs DIVISLAB: Share Price, Valuation & Which to Buy | DocStoX